Well, this bodes well for a mixed-label pivotal study. I wonder whether our application for ODD in Europe will be amended to include CTCL. At least now, the team won't have to make the difficult decision as to which TCL gets dropped from further study. This is great news!
- Forums
- ASX - By Stock
- Ann: FDA grants broader orphan drug status to PTX100 for TCLs
Well, this bodes well for a mixed-label pivotal study. I wonder...
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.1¢ |
Change
-0.002(4.65%) |
Mkt cap ! $33.01M |
Open | High | Low | Value | Volume |
4.1¢ | 4.2¢ | 4.1¢ | $1.449K | 34.97K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 47170 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 160224 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 47170 | 0.041 |
7 | 518294 | 0.040 |
8 | 657589 | 0.039 |
6 | 838222 | 0.038 |
9 | 883000 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 160224 | 1 |
0.043 | 269571 | 4 |
0.044 | 384807 | 4 |
0.045 | 423919 | 4 |
0.046 | 198002 | 2 |
Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |